Growing community of inventors

Seoul, South Korea

Yhun Yhong Sheen

Average Co-Inventor Count = 8.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 13

Yhun Yhong SheenDae-Kee Kim (4 patents)Yhun Yhong SheenChenghua Jin (4 patents)Yhun Yhong SheenChul-Yong Park (4 patents)Yhun Yhong SheenSudhakar Rao Kota (3 patents)Yhun Yhong SheenSreenu Domalapally (3 patents)Yhun Yhong SheenKrishnaiah Maddeboina (3 patents)Yhun Yhong SheenSubrahmanyam Vura Bala (3 patents)Yhun Yhong SheenDomalapally Sreenu (1 patent)Yhun Yhong SheenKota Sudhakar Rao (1 patent)Yhun Yhong SheenMaddeboina Krishnaiah (1 patent)Yhun Yhong SheenVura Bala Subrahmanyam (1 patent)Yhun Yhong SheenCheng Hua Jin (0 patent)Yhun Yhong SheenDae Kee Kim (1 patent)Yhun Yhong SheenCheng Hua Jin (1 patent)Yhun Yhong SheenDae Kee Kim (0 patent)Yhun Yhong SheenCheng Hua Jin (0 patent)Yhun Yhong SheenYhun Yhong Sheen (4 patents)Dae-Kee KimDae-Kee Kim (13 patents)Chenghua JinChenghua Jin (4 patents)Chul-Yong ParkChul-Yong Park (4 patents)Sudhakar Rao KotaSudhakar Rao Kota (3 patents)Sreenu DomalapallySreenu Domalapally (3 patents)Krishnaiah MaddeboinaKrishnaiah Maddeboina (3 patents)Subrahmanyam Vura BalaSubrahmanyam Vura Bala (3 patents)Domalapally SreenuDomalapally Sreenu (1 patent)Kota Sudhakar RaoKota Sudhakar Rao (1 patent)Maddeboina KrishnaiahMaddeboina Krishnaiah (1 patent)Vura Bala SubrahmanyamVura Bala Subrahmanyam (1 patent)Cheng Hua JinCheng Hua Jin (0 patent)Dae Kee KimDae Kee Kim (1 patent)Cheng Hua JinCheng Hua Jin (1 patent)Dae Kee KimDae Kee Kim (0 patent)Cheng Hua JinCheng Hua Jin (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Ewha University-Industry Collaboration Foundation (4 from 177 patents)


4 patents:

1. RE47141 - Methods of treating fibrosis, cancer and vascular injuries

2. RE47122 - 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors

3. 8513222 - Methods of treating fibrosis, cancer and vascular injuries

4. 8080568 - 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…